Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Recruiting · NCT06400537 · Registry updated 2025-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2025-09-17 | NCT06400537 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ITabMed Co., Ltd. | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 319 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanxi Bethune Hospital | Taiyuan | China | 26 |
| Wuhan Union Hospital | Wuhan | China | 10 |